馬立巴韋|T2162

價格	￥769	￥1120	￥1830
包裝	1mg	2mg	5mg

最小起訂量	1mg
發(fā)貨地	上海
更新日期	2024-12-02

QQ交談微信洽談

產(chǎn)品詳情

中文名稱:馬立巴韋	英文名稱:Maribavir
CAS:176161-24-3	品牌: TargetMol
產(chǎn)地: 美國	保存條件: Powder: -20°C for 3 years \| In solvent: -80°C for 1 year \| Shipping with blue ice.
純度規(guī)格: 99.85%	產(chǎn)品類別: 抑制劑
貨號: T2162

Product Introduction

Bioactivity

名稱	Maribavir
描述	Maribavir (GW257406X) is an orally available benzimidazole riboside compound with activity against cytomegalovirus (CMV). Maribavir is a selective ATP competitor of the viral UL97 kinase, which is involved in viral nuclear maturation events, such as viral DNA assembly and movement of viral capsids from the nucleus of infected cells. Maribavir has activity against strains of CMV that are resistant to standard anti-CMV agents.
細(xì)胞實驗	Maribavir (1263W94) is dissolved in DMSO and stored, and then diluted with appropriate media before use[2]. For these studies MRC-5 cells are seeded in 24-well plates at ~5×104 cells/well and grown for 3 days in MEM 8-1-1 to confluence (~1.1×105 cells/well). The cells are infected with AD169 in MEM 2-1-1 at an MOI ranging from 1 to 3 and incubated at 37°C for 90 min to allow viral adsorption. The unadsorbed virus is removed and replaced with 1 mL of MEM 2-1-1. To test the effect of compounds on viral DNA synthesis or maturation, Maribavir, BDCRB, or GCV is added to the medium at the concentrations indicated for each experiment[2].
激酶實驗	Enzyme kinetic analysis is performed on the purified wild type and mutant UL97 protein species using increasing concentrations of ATP (2 μM to 20 μM). The amount of incorporated radiolabelled phosphate is plotted against the concentration of ATP in a Lineweaver Burke plot to determine the Km for ATP for each UL97 species. The effect of Maribavir upon the rate of radiolabelled phosphate incorporation by wild type or mutant UL97 is determined by protein kinase assays at a fixed concentration of Maribavir (0.5 μM) as above, or with increasing concentrations of Maribavir (0.01 μM to 5.0 μM) to determine the IC50 of Maribavir for each UL97 species. In order to determine the nature of the inhibition mediated by Maribavir, plots of 1/v vs 1/ATP with increasing concentrations of Maribavir are constructed. Competitive inhibition is evident if the family of lines cconverged on the y-axis at 1/Vmax. The change in slope caused by the addition of Maribavir is used to calculate the Ki[1].
體外活性	Maribavir是一種強效的抑制劑，能夠有效抑制野生型及所有主要的Ganciclovir（GCV）耐藥UL97突變體的自磷酸化，平均IC50值為35 nM。M460I突變體對Maribavir表現(xiàn)出超敏感性，IC50值為4.8 nM。Maribavir耐藥的UL97突變體（L397R）在功能上受到損害，無論作為Ganciclovir激酶還是蛋白激酶的表現(xiàn)都大大降低（約為野生型的10%）。酶動力學(xué)實驗表明，Maribavir是ATP的競爭性抑制劑，Ki值為10 nM[1]。Maribavir（1263W94）能夠以劑量依賴的方式抑制病毒復(fù)制，通過多周期DNA雜交分析測得的IC50為0.12±0.01 μM。pUL97蛋白激酶被Maribavir強烈抑制，50%抑制濃度為3 nM[2]。
存儲條件	Powder: -20°C for 3 years \| In solvent: -80°C for 1 year \| Shipping with blue ice.
溶解度	DMSO : 60 mg/mL (159.47 mM)
關(guān)鍵字	inhibit \| Cytomegalovirus \| CMV \| Inhibitor \| Maribavir
相關(guān)產(chǎn)品	Resiquimod \| RO8191 \| Honokiol \| Grazoprevir \| Artemisinin \| EIDD-1931 \| Methyl 2-amino-5-bromobenzoate \| Deferiprone \| HCV-IN-30 \| Ribavirin \| HCV-IN-29 \| Sofosbuvir
相關(guān)庫	經(jīng)典已知活性庫 \| 已知活性化合物庫 \| EMA 上市藥物庫 \| FDA上市及藥典收錄分子庫 \| NO PAINS 化合物庫 \| 抗COVID-19化合物庫 \| 抗病毒庫 \| FDA 上市藥物庫 \| 藥物功能重定位化合物庫 \| 人代謝物化合物庫

關(guān)鍵字：馬立巴韋|||GW257406X|||BW1263W94|||Benzimidavir|||1263W94|TargetMol

公司簡介

上海陶術(shù)生物科技有限公司為美國Target Molecule Corp. ( Target Mol ) 在上海建立的全資子公司。我們與美國波士頓、德國慕尼黑的同事一起，為北美、歐洲和亞洲從事藥物研發(fā)和生物學(xué)研究的科學(xué)家提供優(yōu)質(zhì)的產(chǎn)品和專業(yè)的服務(wù)。公司下設(shè)篩選事業(yè)部，化學(xué)事業(yè)部，生物事業(yè)部和新材料部。從虛擬篩選到實體化合物分子供應(yīng)；從商業(yè)化產(chǎn)品銷售到個性化定制合成；從對明確靶點的分子篩選到對明確分子的多靶點篩選，從高通量篩選到化學(xué)結(jié)構(gòu)優(yōu)化，我們都可以滿足您的科研用品及技術(shù)服務(wù)的需求。經(jīng)過在中國市場五年的精心耕耘，我們已成為篩選化合物領(lǐng)域優(yōu)秀的供應(yīng)商，為超過五百家學(xué)校和各類企業(yè)提供了品質(zhì)卓越的小分子化合物和藥物篩

成立日期	2013-04-18 （12年）	注冊資本	566.2651萬人民幣
員工人數(shù)	100-500人	年營業(yè)額	￥ 1億以上
主營行業(yè)	化學(xué)試劑,生物活性小分子	經(jīng)營模式	貿(mào)易,試劑,定制,服務(wù)

TargetMol中國（陶術(shù)生物）

VIP 12年

公司成立：12年
注冊資本：566.2651萬人民幣
企業(yè)類型：有限責(zé)任公司(自然人投資或控股)
主營產(chǎn)品：小分子抑制劑，藥物篩選化合物庫，天然產(chǎn)物，活性分子化合物等
公司地址：上海市閘北區(qū)江場三路28號4樓

進(jìn)入店鋪

詢盤

店內(nèi)推薦

3-三氟甲基苯甲醛|T9367

￥108

甘氨酰-L-谷氨酰胺一水合物|T8171

￥137

棕櫚酸甲酯|T2S0157

￥417